한글목차

전 세계 정밀의료 시장 규모는 2025년에 1,029억 3,000만 달러로 추정되며, 2032년에는 2,206억 8,000만 달러에 달할 것으로 예상되며, 2025-2032년 연평균 11.5%의 성장률을 보일 것으로 예상됩니다.

그림. 정밀의료 시장 점유율(%), 2025년, 지역별

정밀의료는 유전자, 환경, 생활습관의 개인차를 고려한 질병 치료와 예방을 위한 새로운 접근법입니다. 이 접근법을 통해 의사와 연구자들은 특정 질병에 대한 치료 및 예방 전략이 어떤 그룹에 효과적일지 보다 정확하게 예측할 수 있습니다. 이는 모든 사람에게 획일적인 방식으로 질병을 치료하는 '획일적' 접근 방식과는 대조적입니다. 정밀의료는 유전자 정보와 분자진단학을 통합하여 환자 개개인의 특성에 따라 맞춤형 치료를 하는 것입니다. 의사는 환자의 유전적 체질을 더 잘 알면 특정 약물이나 생활습관 개선, 치료의 효과 여부, 또는 개인별로 다른 옵션을 고려해야 하는지 여부를 판단할 수 있습니다. 이를 통해 연구자와 의료진은 각 환자에게 가장 안전한 치료법을 결정할 수 있어 치료 결과를 개선할 수 있습니다. 지속적인 연구개발을 통해 정밀의료는 표적화된 질병 예방과 치료를 통해 의료를 변화시킬 것으로 기대됩니다.

시장 역학:

세계 정밀의료 시장은 맞춤형 의료에 대한 수요 증가, 정밀 치료제 개발을 위한 R&D 투자 증가, 정밀의료에서 차세대 염기서열 분석기(NGS)의 적용 확대, 의료비 절감에 대한 수요 급증에 의해 주도되고 있습니다. 그러나 데이터 해석과 표준화의 부족, 치료비 상승이 시장 성장을 억제할 것으로 예상됩니다. 반면, 신흥국은 시장 기업들에게 높은 성장 기회를 제공하고 있습니다. 정밀의료 접근법은 기존 치료법에 비해 효능이 향상되고 부작용이 감소된 표적 치료를 제공함으로써 급성장하고 있는 여러 의료 문제를 해결하는 데 도움이 될 수 있습니다. 동반진단의 채택이 증가하고 의약품 개발 활동에 정밀의료가 통합되는 것도 새로운 기회를 제공하고 있습니다.

본 조사의 주요 특징

• 세계의 정밀의료 시장을 상세히 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년)의 시장 규모와 CAGR(연평균 성장률)을 조사하여 전해드립니다.
• 또한, 다양한 부문에 걸친 잠재적인 수익 성장 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 주요 인사이트를 제공합니다.
• 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 정밀 의료 시장의 주요 기업을 프로파일링합니다.
• 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 정밀의료 세계 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 정밀의료 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.

목차

제1장 조사 목적과 가정

• 조사 목적
• 가정
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
• 성장 촉진요인
• 성장 억제요인
• 시장 기회
• 영향 분석
• 시장 동향
• 인수와 제휴 시나리오
• 진행중인 개발
• Porters 분석
• PEST 분석

제4장 세계의 정밀의료 시장 : COVID-19 팬데믹의 영향

• 전체적인 영향
• 정부 이니셔티브
• COVID-19의 시장에 대한 영향

제5장 세계의 정밀의료 시장 : 기술별(2020-2032년)

• 바이오인포매틱스
• 유전자 시퀀싱
• Drug Discovery
• 정밀 분자진단
• 빅데이터 분석

제6장 세계의 정밀의료 시장 : 용도별(2020-2032년)

• 종양학
• 중추신경계
• 혈액학
• 면역학
• 호흡기
• 기타

제7장 세계의 정밀의료 시장 : 지역별(2020-2032년)

• 지역별 시장 점유율 분석 : 2025년 및 2032년(%)
• 지역별 전년비 성장 분석
• 지역 동향
• 북미
  • 기술별 시장 규모와 예측, 전년비 성장률
  • 용도별 시장 규모와 예측, 전년비 성장률
  • 국가별 시장 규모와 예측, 전년비 성장률
  • 미국
  • 캐나다
• 라틴아메리카
  • 브라질
  • 멕시코
  • 아르헨티나
  • 기타 라틴아메리카
• 유럽
  • 영국
  • 독일
  • 이탈리아
  • 프랑스
  • 스페인
  • 러시아
  • 기타 유럽
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • ASEAN
  • 호주
  • 한국
  • 기타 아시아태평양
• 중동
  • GCC 국가
  • 이스라엘
  • 기타 중동
• 아프리카
  • 북아프리카
  • 중앙아프리카
  • 남아프리카공화국

제8장 경쟁 구도

• Intomics
• GENinCode
• NanoString
• Tepnel Pharma Services Limited
• Pfizer Inc.
• Novartis AG
• Teva Pharmaceutical Industries Ltd.
• Merck & Co., Inc
• QIAGEN
• Quest Diagnostics Incorporated
• Medtronic
• Thermo Fisher Scientific Inc.
• Laboratory Corporation of America Holdings
• bioMerieux SA
• F. Hoffmann-La Roche Ltd
• Eli Lilly & Company
• GlaxoSmithKline plc
• Cepheid
• AstraZeneca PLC
• Myriad Genetics, Inc.
• Bristol-Myers Squibb Company

제9장 애널리스트의 견해

• Wheel of Fortune
• 애널리스트의 견해
• Coherent Opportunity Map(COM)

제10장 참고문헌과 조사 방법

• 참고문헌
• 조사 방법

영문목차

Global Precision Medicine Market is estimated to be valued at USD 102.93 Bn in 2025 and is expected to reach USD 220.68 Bn by 2032, growing at a compound annual growth rate (CAGR) of 11.5% from 2025 to 2032.

Figure. Precision Medicine Market Share (%), By Region 2025

Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person. This approach allows doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a "one-size-fits-all" approach, where disease treatment is a standardized approach for all people. Precision medicine integrates genetic information and molecular diagnostics to tailor medical treatments based on the individual characteristics of each patient. With greater knowledge of patients' genetic makeup, doctors can determine if certain medicines, lifestyle changes, or treatments will help or if different options may need to be considered depending on the individual. This allows researchers and healthcare providers to determine the safest treatment option tailored for each patient, leading to improved treatment outcomes. With continued research and development, precision medicine holds promise to transform healthcare through targeted disease prevention and treatment.

Market Dynamics:

The global precision medicine market is driven by the increasing demand for personalized healthcare, rise in R&D investments for precision therapeutics development, growing application of next-generation sequencing (NGS) in precision medicine, and surging demand for healthcare reduction. However, the lack of data interpretation & standardization and high cost of treatment are expected to restrain the market growth. Meanwhile, emerging economies offer high-growth opportunities for market players. Precision medicine approaches could help address several burgeoning healthcare challenges by offering targeted therapeutics with improved efficacy and reduced side-effects compared to conventional treatment methods. The growing adoption of companion diagnostics and inclusion of precision medicine in drug development activities also presents new opportunities.

Key Features of the Study:

• This report provides an in-depth analysis of the global precision medicine market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global precision medicine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Intomics, GENinCode, NanoString, Tepnel Pharma Services Limited, Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc, QIAGEN, Quest Diagnostics Incorporated, Medtronic, Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, bioMerieux SA, F. Hoffmann-La Roche Ltd, Eli Lilly & Company, GlaxoSmithKline plc, Cepheid, AstraZeneca PLC, Myriad Genetics Inc., and Bristol-Myers Squibb Company
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global precision medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global precision medicine market.

Market Segmentation

• Technology:
  • Bioinformatics
  • Gene Sequencing
  • Precision Molecular Diagnostics
  • Big Data Analytics
  • Others
• Application:
  • Oncology
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Others
  • Central Nervous System
  • Hematology
  • Immunology
  • Respiratory
  • Others
• End User:
  • Biopharmaceutical Companies
  • Diagnostic Laboratories
  • Academic & Research Institutions
  • Others
• Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
• Company Profiles:
  • Intomics
  • GENinCode
  • NanoString
  • Tepnel Pharma Services Limited
  • Pfizer Inc.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Merck & Co. Inc
  • QIAGEN
  • Quest Diagnostics Incorporated
  • Medtronic
  • Thermo Fisher Scientific Inc.
  • Laboratory Corporation of America Holdings
  • bioMerieux SA
  • Hoffmann-La Roche Ltd
  • Eli Lilly & Company
  • GlaxoSmithKline plc
  • Cepheid
  • AstraZeneca PLC
  • Myriad Genetics Inc.
  • Bristol-Myers Squibb Company

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Technology
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Drivers
• Restraints
• Market Opportunities
• Impact Analysis
• Market Trends
• Acquisitions and Partnerships Scenario
• Ongoing Developments
• Porter's Analysis
• PEST Analysis

4. Global Precision Medicine Market- Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Precision Medicine Market, By Technology, 2020 - 2032, (US$ Billion)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Bioinformatics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Gene Sequencing
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Drug Discovery
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Precision Molecular Diagnostics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Big Data Analytics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

6. Global Precision Medicine Market, By Application, 2020 - 2032, (US$ Billion)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Oncology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Others
• Central Nervous System
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Hematology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Immunology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Respiratory
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

7. Global Precision Medicine Market, By Region, 2020 - 2032, (US$ Billion)

• Introduction
• Market Share Analysis, By Region, 2025 and 2032 (%)
• Y-o-Y Growth Analysis, For Regions, 2020-2032
• Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
  • U.S.
  • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
  • UK
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (US$ Billion)
  • North Africa
  • Central Africa
  • South Africa

8. Competitive Landscape

• Intomics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• GENinCode
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• NanoString
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Tepnel Pharma Services Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Novartis AG
• Teva Pharmaceutical Industries Ltd.
• Merck & Co., Inc
• QIAGEN
• Quest Diagnostics Incorporated
• Medtronic
• Thermo Fisher Scientific Inc.
• Laboratory Corporation of America Holdings
• bioMerieux SA
• F. Hoffmann-La Roche Ltd
• Eli Lilly & Company
• GlaxoSmithKline plc
• Cepheid
• AstraZeneca PLC
• Myriad Genetics, Inc.
• Bristol-Myers Squibb Company

9. Analyst View

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact